Chealcomm chealcomm.jp


Public lists: Medical Devices (6123)

Chealcomm is a Japanese based MVNO that specialized in providing advanced wireless medical and wellness services to the Japanese home market. The company aims to utilize KDDI's network and offers a family of medical devices that have CDMA 2000 modules integrated into them. www.chealcomm.jp/

Chealcomm is a Japanese based MVNO that specialized in providing advanced wireless medical and wellness services to the Japanese home market. The company aims to utilize KDDI's network and offers a family of medical devices that have CDMA 2000 module...Show all

Company (Alive / Active)

Phone: 036-272-6790

Fax:

3-4-29 Kanda Jinbo-cho, Chiyoda-ku, Tokyo 502 Kudanshita SST Bill


Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Chealcomm $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Chealcomm Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Chimerix

Durham, North Carolina, United States
IPO / Went publicChimerix is developing antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Based on lipid conjugate technology, the company's two clinical stage compounds have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. CMX001 is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofovir-diphosp...Show allLogin to see details

Es Vascular

Israel
Alive / ActiveES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israe...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)